Home › Funds › Distillate Capital Partners LLC › UTHR
Distillate Capital Partners LLC position in UTHR
UNITED THERAPEUTICS CORP DEL · Health Care
Distillate Capital Partners LLC reported holding 36,268 shares of UTHR (UNITED THERAPEUTICS CORP DEL) in its Q3 2026 13F filing — a position valued at US$19.7M, representing 0.94% of its reported portfolio and ranking #43 among its reported holdings. Distillate Capital Partners LLC has disclosed UTHR holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Distillate Capital Partners LLC's UTHR position evolved
Distillate Capital Partners LLC first disclosed a stake in UTHR in Q2 2026 at 26,967 shares (US$14.6M). The position peaked in Q3 2026 at 36,268 shares, worth US$19.7M. Across 2 filings, Distillate Capital Partners LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 36,268 shares valued at US$19.7M — an increase of 9,301 shares quarter over quarter.. Notable position changes include a 34% increase in Q3 2026 (shares rose 8% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 26.97K | $14.61M | New |
| Q3 2026 | 36.27K | $19.65M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About UTHR and 13F data
UTHR (UNITED THERAPEUTICS CORP DEL) is a Health Care company. 38 other funds we track also report a position in UTHR — the largest reported positions include Avoro Capital Advisors LLC (US$1.49B), Renaissance Technologies (US$908.2M), ASSETMARK, INC (US$325.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding UTHR
- Avoro Capital Advisors LLC 2.76M sh · $1.49B · Q3 2026
- Renaissance Technologies 1.68M sh · $908.15M · Q3 2026
- ASSETMARK, INC 600.17K sh · $325.23M · Q3 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 540.60K sh · $292.94M · Q3 2026
- Vestal Point Capital, LP 475.00K sh · $257.40M · Q3 2026
- Eversept Partners, LP 324.73K sh · $175.97M · Q3 2026
- Deep Track Capital, LP 300.04K sh · $162.59M · Q3 2026
- Soleus Capital Management, L.P. 259.00K sh · $140.35M · Q3 2026
More on Distillate Capital Partners LLC
FAQ
How long has Distillate Capital Partners LLC held UTHR?
Distillate Capital Partners LLC has disclosed UTHR holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Distillate Capital Partners LLC's current position in UTHR?
As of Q3 2026, Distillate Capital Partners LLC holds 36.27K shares of UTHR (UNITED THERAPEUTICS CORP DEL), valued at $19.65M, representing 0.94% of its reported portfolio and ranking #43.
Has Distillate Capital Partners LLC been buying or selling UTHR?
In the latest 13F filing (Q3 2026), Distillate Capital Partners LLC increased its position in UTHR. The position peaked in Q3 2026 at 36.27K shares.
Which other funds hold UTHR?
Other major institutional holders of UTHR include Avoro Capital Advisors LLC, Renaissance Technologies, ASSETMARK, INC, among 38 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.